CC
Cheryl Cohen sold $851K of IBRX stock
Cheryl Cohen, Dir of ImmunityBio, Inc. (IBRX), sold 81,056 shares of IBRX stock worth $851K, per an SEC Form 4 filed Oct 6, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 2, 2026, 4 days before it was made public.
IBRX has moved -41.9% since the trade date, from $10.29 to $5.98 (Nov 16, 2026 close).
- Traded
- Oct 2, 2026
- Disclosed
- Oct 6, 2026
- Filing delay
- 4 days
- Price since
- -41.9%
- Role
- Dir
- Source
- SEC Form 4